PCN151 COST-EFFECTIVENESS ANALYSIS OF ATEZOLIZUMAB FOR WOMEN WITH METASTATIC TRIPLE NEGATIVE BREAST CANCER IN FRANCE

التفاصيل البيبلوغرافية
العنوان: PCN151 COST-EFFECTIVENESS ANALYSIS OF ATEZOLIZUMAB FOR WOMEN WITH METASTATIC TRIPLE NEGATIVE BREAST CANCER IN FRANCE
المؤلفون: B. Tehard, C. Ouared, Stéphane Roze, A. Gherardi
المصدر: Value in Health. 22:S464-S465
بيانات النشر: Elsevier BV, 2019.
سنة النشر: 2019
مصطلحات موضوعية: Oncology, medicine.medical_specialty, business.industry, Atezolizumab, Health Policy, Internal medicine, Public Health, Environmental and Occupational Health, Medicine, Cost-effectiveness analysis, business, Triple-negative breast cancer
تدمد: 1098-3015
URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::55546e68109e3da1b5af45c2e641e45e
https://doi.org/10.1016/j.jval.2019.09.347
حقوق: OPEN
رقم الأكسشن: edsair.doi...........55546e68109e3da1b5af45c2e641e45e
قاعدة البيانات: OpenAIRE